| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Jun Lu CEO | XSHE Exchange | CNE1000056T2 ISIN |
| CN Country | 783 Employees | 9 Jun 2026 Last Dividend | 16 May 2023 Last Split | - IPO Date |
Caina Technology Co., Ltd. is a prominent enterprise specializing in the research, development, manufacturing, and marketing of a wide array of injection needles, syringes, and various other related medical devices. Established in the year 2004, this company prides itself on offering innovative solutions in the medical field, focusing on safety, effectiveness, and the prevention of communicable diseases. Based in Jiangyin, China, Caina Technology has positioned itself as a key player in the medical device industry, contributing significantly to enhancing healthcare standards and patient safety on a global scale.
These are designed to prevent reuse, thus curbing the spread of infections. After a single use, the syringe becomes inoperable, ensuring patient safety and compliance with global health standards.
Specifically crafted for diabetes patients, these syringes allow for accurate insulin dosages, ensuring ease of use and minimizing discomfort during the injection process.
These are made for use with insulin pens, providing a convenient, pain-free way for diabetes patients to manage their condition. The sterility assures safety with every injection.
Used for collecting blood samples, these needles are manufactured with patient safety and comfort in mind, ensuring high-quality samples are collected with minimum pain.
Caina Technology also offers a vast range of other sterile medical products, all designed with the same commitment to quality, safety, and innovation, addressing various needs within the medical community.